�Clinical information utilizing the DRX9000 True Non-Surgical Spinal Decompression System� will be presented at the PainWeek Conference in Las Vegas, September xlvi, 2008. The first, is an IRB-approved, prospective multi-center phase II, non-randomized pilot study authored by Dr. John Leslie of the Mayo Clinic and others. This study was intentional to judge the effectivity and safety of the DRX9000 in treating continuing lower plump for pain. A greater than 50% reduction in painfulness score was observed afterwards two weeks of treatment, and upon completion of the entire six week protocol an amazing achiever rate of 88.9% was documented. Improvement of Oswestry tons and a decreased usance of adjunctive pain medication was likewise noted. The second, is retrospective information which included lumbar spine CT scans before and after patients were treated on the DRX9000 that demonstrates possible morphological changes associated with treatment. Dr. Christian Apfel, MD, Associate Professor of Anesthesiology and Perioperative Care at the University of California at San Francisco, will award this data at the PainWeek Conference. Dr. Apfel, lead source and his colleagues conclude, "A significant reduction in chronic LBP [lower indorse pain] after non-invasive spinal anesthesia decompression correlated with an increase in disc stature." Abstracts of both studies will be available during the 2008 PainWeek Conference.
Non-treatment or control groups were non included qualification efficacy outcome versus placebo or spontaneous recovery difficult to determine. Randomized double-blinded or comparative long-term issue trials are needed to further leaven the efficacy of nonsurgical spinal decompression systems such as the DRX9000� for the turn treatment of chronic LBP. This study was partly funded by Axiom Worldwide.
A randomised controlled run is needed to prove that restoration in disk height is the mechanism through which non-surgical spinal anesthesia decompression systems such as the DRX9000� leads to these impressive reductions in pain.
Axiom Worldwide manufactures and distributes its flagship products, the DRX9000 True Non-Surgical Spinal Decompression System�, DRX9000C�, and DRX9500� in medical markets around the globe. Axiom also manufactures a digital electroceutical device, the EPS8000�, for habit in relieving pain and for function in muscular rehabilitation. Axiom prides itself on providing safe, nonsurgical alternatives that patients should consider prior to undergoing surgery.
Axiom Worldwide
More information
